Ardagh Metal Packaging (AMBP) is back in play. A Luxembourg judge has cleared Ardagh Holdings to restart the sale process for its metal packaging unit, according to a note from Truist Securities. But the investment bank thinks the most logical strategic buyers are effectively sidelined by regulators.
Truist said Ball Corporation and Crown Holdings, two of the largest can makers in the world, are unlikely to bid for AMBP because a deal would raise serious antitrust concerns in both the United States and Europe. The firm pointed to a telling precedent: AMBP itself was created out of assets that Ball had to divest to win approval for its 2016 acquisition of rival Rexam. That episode showed how aggressively competition authorities scrutinise consolidation in the beverage can industry.
Why the obvious buyers are stuck on the sidelines
The global beverage can market is already highly concentrated. Ball, Crown and Ardagh are the three dominant players, and together they control a large share of can production for soft drinks, beer and other beverages. When a market is that tight, regulators tend to assume that removing even one independent competitor could lead to higher prices for customers, which in this case are the big drink companies and, ultimately, consumers.
The 2016 Ball-Rexam deal is the clearest example. To get the green light, Ball had to sell off a chunk of its European assets, and those assets became part of what is now Ardagh Metal Packaging. Truist's argument is simple: if Ball had to shed plants to buy Rexam, it would face an even tougher path trying to buy back a business built from those very assets. Crown would run into similar objections.
That leaves private equity as the most plausible route. Truist said the sale looks like a private equity job, meaning a financial sponsor rather than an industry buyer is the likely acquirer. Private equity firms have plenty of dry powder and a long track record of buying industrial and packaging businesses, often with the aim of improving operations and eventually selling or listing the company again. The private credit market's large cash pile has also made it easier for buyout firms to finance bigger deals without relying solely on traditional banks.
What this means for investors
For anyone holding AMBP shares, the restart of the sale process is the key catalyst. A successful sale could crystallise value, especially if a private equity buyer is willing to pay a premium to the current share price. But the path is not guaranteed. Sale processes can stall, and the Luxembourg court's involvement suggests there have been legal or structural complications behind the scenes.
Investors should also watch what a private equity deal would mean for the broader packaging sector. If AMBP goes to a financial buyer, it removes the possibility of a large strategic merger that could have reshaped the competitive landscape. That is generally good news for Ball and Crown, which would avoid a costly bidding war and keep their own market positions intact. It may also signal that antitrust scrutiny is now a permanent feature of any large deal in this space.
The packaging industry has been active on the deal front. International Paper has weighed a sale of its EMEA packaging unit, and other industrial companies have attracted unsolicited interest. Private equity has been busy too, with deals like the take-private of CCC Intelligent Solutions and the Penske Automotive buyout showing that sponsors are willing to write large cheques for the right assets.
For everyday investors, the takeaway is not to chase headlines. A sale process can take months, and the outcome depends on financing conditions, regulatory reviews and the willingness of private equity firms to meet the seller's price. AMBP's earnings and cash flow will remain the fundamental drivers in the meantime. If a deal does happen, the terms, especially the price per share and any breakup fee, will matter far more than the speculation leading up to it.
What to watch next: any formal announcement of a buyer, updates from Ardagh on the sale timeline, and whether Ball or Crown make any public comment on their interest. Truist's view is just one analyst's opinion, but it highlights a real constraint that any buyer will have to navigate.
